LMR Partners’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $316K | Sell |
14,524
-15,476
| -52% | -$300K | ﹤0.01% | 1134 |
|
|
2025
Q4 | $646K | Buy |
30,000
+3,083
| +11% | +$65K | 0.01% | 1076 |
|
|
2025
Q3 | $519K | Buy |
+26,917
| New | +$480K | 0.01% | 1083 |
|
|
2025
Q2 | – | Hold |
0
| – | – | – | 1723 |
|
|
2025
Q1 | – | Sell |
-3,724
| Closed | -$453K | – | 1698 |
|
|
2024
Q4 | $453K | Sell |
3,724
-41,903
| -92% | -$5.14M | 0.01% | 852 |
|
|
2024
Q3 | $5.7M | Sell |
45,627
-15,217
| -25% | -$2.1M | 0.13% | 333 |
|
|
2024
Q2 | $9.61M | Buy |
+60,844
| New | +$7.82M | 0.21% | 213 |
|
|
2024
Q1 | – | Sell |
-22,654
| Closed | -$2.78M | – | 1433 |
|
|
2023
Q4 | $2.18M | Buy |
+22,654
| New | +$2.17M | 0.05% | 451 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1087 |
|
|
2023
Q2 | – | Sell |
-44,479
| Closed | -$5.74M | – | 1127 |
|
|
2023
Q1 | $6.13M | Buy |
44,479
+25,389
| +133% | +$3.29M | 0.11% | 226 |
|
|
2022
Q4 | $2.47M | Sell |
19,090
-4,449
| -19% | -$516K | 0.05% | 463 |
|
|
2022
Q3 | $2.6M | Sell |
23,539
-90,121
| -79% | -$9.08M | 0.05% | 439 |
|
|
2022
Q2 | $8.52M | Buy |
113,660
+51,901
| +84% | +$3.82M | 0.15% | 168 |
|
|
2022
Q1 | $4.83M | Buy |
+61,759
| New | +$4.73M | 0.06% | 334 |
|
|
2021
Q3 | – | Sell |
-5,997
| Closed | -$466K | – | 1183 |
|
|
2021
Q2 | $466K | Buy |
+5,997
| New | +$455K | 0.01% | 693 |
|
|
2021
Q1 | – | Sell |
-51,986
| Closed | -$8.86M | – | 1054 |
|
|
2020
Q4 | $8.86M | Buy |
+51,986
| New | +$7.7M | 0.14% | 71 |
|
|
2019
Q3 | – | Sell |
-19,359
| Closed | -$2.94M | – | 507 |
|
|
2019
Q2 | $2.94M | Sell |
19,359
-7,267
| -27% | -$883K | 0.11% | 91 |
|
|
2019
Q1 | $3.17M | Buy |
+26,626
| New | +$3.42M | 0.16% | 93 |
|
|
2018
Q4 | – | Sell |
-37,216
| Closed | -$6.01M | – | 468 |
|
|
2018
Q3 | $6.01M | Sell |
37,216
-59,929
| -62% | -$8.19M | 0.38% | 68 |
|
|
2018
Q2 | $12.8M | Buy |
+97,145
| New | +$9.16M | 0.67% | 27 |
|
Other funds holding SRPT
VPM
VCM
RCM
EAM
